Nuformix Plc (GB:NFX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nuformix plc has announced that its directors have participated in a recent fundraising effort, purchasing substantial shares as part of a £300,000 placement. Notably, Non-Executive Chairman Julian Gilbert and Non-Executive Director Maddy Kennedy each acquired 22 million shares, while Executive Director Dan Gooding purchased 12 million shares. This move underscores the company’s focus on drug repurposing in fibrosis and oncology, potentially signaling confidence in its strategic direction.
For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.
